• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Innocan Pharma Closes Additional Insider Debenture

HERZLIYA-CALGARY – Innocan Pharma Corp. announced that it had completed the closing of an additional secured debenture with its largest shareholder, Tamar Innovest Ltd., for gross proceeds of $200,000. The financing follows the company’s earlier ...

Jushi Reports Q1 2026 Financial Results

BOCA RATON – Jushi Holdings Inc. delivered a quarter of steady operational progress while facing ongoing industry pressures. The multi-state operator recorded year-on-year improvements in revenue and profitability metrics, and completed a significant refinancing of ...

iAnthus Reports Q1 2026 Financial Results

NEW YORK-TORONTO – iAnthus Capital Holdings posted its fiscal first-quarter results for 2026, revealing a company focused on operational tweaks while navigating softer sales in a competitive Cannabis market. The multi-state operator, active across retail ...

Organigram Reports Q2 Fiscal 2026 Results

TORONTO – Organigram Global Inc. released its financial results, marking a quarter shaped by shifts in consumer preferences and execution issues in key categories. The Canadian producer, known for holding the top market share position ...

Hawaii’s Adult-Use Cannabis Legalization Stalls

LOS ANGELES- In a recent development within Hawaii's legislative process, a pivotal House committee announced it will not advance a bill proposing the legalization and regulation of recreational cannabis, effectively halting the legislation for 2024. ...

DEA to Conduct Hearing on Psychedelic Substances Proposal

LOS ANGELES- The Drug Enforcement Administration (DEA) has announced plans to hold a hearing regarding the proposed classification of two psychedelic substances, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC), as Schedule I drugs under the Controlled Substances ...

Alabama Seeks to Expand Medical Cannabis Licensing

LOS ANGELES- In an effort to resolve ongoing legal disputes surrounding its medical cannabis licensing process, Alabama has introduced a bill proposing an increase in the number of available licenses. Filed on Tuesday, the legislation ...

Oregon Reinstates Criminal Penalties for Drug Possession

LOS ANGELES- In a landmark reversal, Oregon Governor Tina Kotek has endorsed House Bill 4002, reintroducing criminal penalties for possession of controlled substances such as fentanyl, heroin, and methamphetamine. This action marks a departure from ...

Alberta Leads in Psychedelic-Assisted Therapy Coverage

NEW YORK- Alberta Blue Cross's recent endorsement of insurance coverage for Psychedelic-Assisted Therapy signifies a pioneering move in Canadian healthcare, positioning Alberta as the first province to officially support and regulate such treatments. This development ...

Ontario Anticipates Record Cannabis Revenue

LOS ANGELES- In a landmark financial forecast, Ontario expects to garner over CA$379 million from its share of the federal cannabis duty for the fiscal year April 2024 to March 2025, marking a significant 22.2% ...

Delaware Expands Medical Cannabis Program Access

NEW YORK- Delaware lawmakers have passed a significant bill aimed at broadening access to the state's medical cannabis program. On Thursday, the Delaware Senate approved a proposal that grants healthcare providers the discretion to certify ...

Maryland Awards Social Equity Cannabis Licenses

LOS ANGELES- In a significant move by the Maryland Cannabis Administration, 174 social equity cannabis licenses were awarded through a lottery system, showcasing the state's commitment to diversity and inclusion within the burgeoning cannabis industry. ...

Organigram Announces Investment in Open Book Extracts

NEW YORK- Organigram Holdings, a Canadian cannabis company, announced a $2 million investment in North Carolina-based Open Book Extracts. This move signifies Organigram's entry into the U.S. cannabis market, facilitated by an investment from British ...

Algernon Pharmaceuticals Advances Research Program

LOS ANGELES – In a significant move that underscores its commitment to innovative medical research, Algernon Pharmaceuticals Inc. announced its decision to prioritize its AP-188 ("N,N-Dimethyltryptamine" or "DMT") stroke research program. This announcement follows the ...

Glass House Brands Report Revenue and Profits

LOS ANGELES- In a notable financial turnaround, Glass House Brands, a California-based cannabis producer and retailer, reported significant growth in its fourth-quarter earnings, leading to a record revenue of $160.8 million for the fiscal year ...

ICER Raises Concerns Over MDMA-Assisted Psychotherapy for PTSD

LOS ANGELES- The Institute for Clinical and Economic Review (ICER) has recently highlighted significant concerns regarding the clinical evidence behind MDMA-assisted psychotherapy (MDMA-AP) for post-traumatic stress disorder (PTSD), according to a draft evidence report. This ...

Psilera Strengthens Board with Neuroscience

TAMPA –Psilera, a biotechnology company specializing in novel treatments for complex neurological disorders, has announced the addition of Dr. Magali Haas, M.D., Ph.D., to its Board of Directors. Dr. Haas, with an illustrious career spanning ...

Subscribe To Our Newsletter

Go to Top